Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 07-2015 | 04-2015 | 01-2015 | 10-2014 | 07-2014 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 12 | 13 | 10 | 0 | 0 |
| Accounts receivable | -26 | -5 | 44 | -61 | 32 |
| Other Working Capital | -17 | 19 | 1 | 35 | -10 |
| Other Operating Activity | -184 | -132 | -151 | 13 | -144 |
| Operating Cash Flow | $-214 | $-105 | $-96 | $-12 | $-121 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | -34 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -192 | 0 |
| Investing Cash Flow | $0 | $0 | $-34 | $-192 | $N/A |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $0 | $N/A | $N/A | $N/A | $N/A |
| Exchange Rate Effect | 35 | -15 | 50 | 37 | N/A |
| Beginning Cash Position | 462 | 282 | 362 | 529 | 651 |
| End Cash Position | 283 | 462 | 282 | 362 | 529 |
| Net Cash Flow | $-214 | $195 | $-130 | $-204 | $-121 |
| Free Cash Flow | |||||
| Operating Cash Flow | -214 | -105 | -96 | -12 | -121 |
| Capital Expenditure | N/A | N/A | -34 | N/A | N/A |
| Free Cash Flow | -214 | -105 | -130 | -12 | -121 |